
Jehanne Souaya Sitton
Examiner (ID: 17461, Phone: (571)272-0752 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682, 1655 |
| Total Applications | 1479 |
| Issued Applications | 528 |
| Pending Applications | 307 |
| Abandoned Applications | 653 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19226915
[patent_doc_number] => 12006549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Methods utilizing leukocyte RNA expression in prognosis evaluation of medical interventions for epilepsy
[patent_app_type] => utility
[patent_app_number] => 17/269092
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7136
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269092 | Methods utilizing leukocyte RNA expression in prognosis evaluation of medical interventions for epilepsy | Oct 3, 2019 | Issued |
Array
(
[id] => 15899191
[patent_doc_number] => 20200149114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => DISCOVERY OF A SOMATIC MUTATION IN MYD88 GENE IN LYMPHOPLASMACYTIC LYMPHOMA
[patent_app_type] => utility
[patent_app_number] => 16/580523
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580523 | Discovery of a somatic mutation in MYD88 gene in lymphoplasmacytic lymphoma | Sep 23, 2019 | Issued |
Array
(
[id] => 17370418
[patent_doc_number] => 20220025470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => USE OF PROBES TO DETECT TOXIC ALGAE, DETECTION METHOD AND CORRESPONDING KITS
[patent_app_type] => utility
[patent_app_number] => 17/277020
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17277020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/277020 | USE OF PROBES TO DETECT TOXIC ALGAE, DETECTION METHOD AND CORRESPONDING KITS | Sep 16, 2019 | Abandoned |
Array
(
[id] => 19368537
[patent_doc_number] => 12060611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Gene expression profiles associated with sub-clinical kidney transplant rejection
[patent_app_type] => utility
[patent_app_number] => 16/569119
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 66916
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 782
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/569119 | Gene expression profiles associated with sub-clinical kidney transplant rejection | Sep 11, 2019 | Issued |
Array
(
[id] => 16206967
[patent_doc_number] => 20200239957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => PREDICTION AND TREATMENT OF HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/564886
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16564886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/564886 | PREDICTION AND TREATMENT OF HEART FAILURE | Sep 8, 2019 | Abandoned |
Array
(
[id] => 16688774
[patent_doc_number] => 20210071250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA
[patent_app_type] => utility
[patent_app_number] => 16/562861
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/562861 | DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA | Sep 5, 2019 | Pending |
Array
(
[id] => 18779346
[patent_doc_number] => 11821041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Non-invasive test to predict recurrence of colorectal cancer
[patent_app_type] => utility
[patent_app_number] => 16/534028
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3760
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16534028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/534028 | Non-invasive test to predict recurrence of colorectal cancer | Aug 6, 2019 | Issued |
Array
(
[id] => 15832605
[patent_doc_number] => 20200131584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => BIOMARKER DLEC1 FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/530416
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/530416 | Biomarker DLEC1 for cancer | Aug 1, 2019 | Issued |
Array
(
[id] => 16177308
[patent_doc_number] => 20200224276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => ncRNA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/523008
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523008
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523008 | NcRNA and uses thereof | Jul 25, 2019 | Issued |
Array
(
[id] => 20357611
[patent_doc_number] => 12473599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Gene signatures for predicting metastasis of melanoma and patient prognosis
[patent_app_type] => utility
[patent_app_number] => 17/262175
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 17022
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262175
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262175 | Gene signatures for predicting metastasis of melanoma and patient prognosis | Jul 24, 2019 | Issued |
Array
(
[id] => 16870589
[patent_doc_number] => 20210164056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => USE OF METASTASES-SPECIFIC SIGNATURES FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/262471
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262471
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262471 | USE OF METASTASES-SPECIFIC SIGNATURES FOR TREATMENT OF CANCER | Jul 23, 2019 | Pending |
Array
(
[id] => 17067668
[patent_doc_number] => 20210269883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => PREDICTIVE AND PROGNOSTIC USE OF A miRNA FOR HIGH GRADE SEROUS OVARIAN CARCINOMA THERAPEUTIC CARE
[patent_app_type] => utility
[patent_app_number] => 17/253363
[patent_app_country] => US
[patent_app_date] => 2019-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253363 | Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care | Jul 3, 2019 | Issued |
Array
(
[id] => 19826492
[patent_doc_number] => 12247258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, in particular in newborns
[patent_app_type] => utility
[patent_app_number] => 17/255657
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 4
[patent_no_of_words] => 8035
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255657 | Epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, in particular in newborns | Jul 2, 2019 | Issued |
Array
(
[id] => 15963861
[patent_doc_number] => 20200165682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => ncRNA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/453195
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29718
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16453195
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/453195 | ncRNA and uses thereof | Jun 25, 2019 | Issued |
Array
(
[id] => 18636456
[patent_doc_number] => 11761044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Method for evaluating whether an individual with cancer is suitable for treatment with a CDK inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/451942
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 46
[patent_no_of_words] => 11408
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16451942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/451942 | Method for evaluating whether an individual with cancer is suitable for treatment with a CDK inhibitor | Jun 24, 2019 | Issued |
Array
(
[id] => 16191190
[patent_doc_number] => 20200232039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => ADM2 GENE MARKER FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF THYROID CANCER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/445322
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445322 | ADM2 GENE MARKER FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF THYROID CANCER AND USES THEREOF | Jun 18, 2019 | Abandoned |
Array
(
[id] => 15254823
[patent_doc_number] => 20190376145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => PREDICTION OF POOR RESPONSE TO NEOADJUVANT CHEMORADIATION IN RECTAL CANCER PATIENTS USING A DNA REPAIR SCORE
[patent_app_type] => utility
[patent_app_number] => 16/439027
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16439027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/439027 | Prediction of poor response to neoadjuvant chemoradiation in rectal cancer patients using a DNA repair score | Jun 11, 2019 | Issued |
Array
(
[id] => 16992167
[patent_doc_number] => 20210230587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => NOVEL METHOD FOR STABILIZING NUCLEIC ACID NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 15/734938
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734938
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734938 | Method for stabilizing nucleic acid nanostructures | Jun 4, 2019 | Issued |
Array
(
[id] => 16992290
[patent_doc_number] => 20210230710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS FOR DETECTING ANTIVIRAL-DRUG RESISTANT VIRUS
[patent_app_type] => utility
[patent_app_number] => 15/734910
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734910
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734910 | Methods for detecting antiviral-drug resistant virus | Jun 3, 2019 | Issued |
Array
(
[id] => 14808875
[patent_doc_number] => 20190271047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 16/416083
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/416083 | PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS | May 16, 2019 | Abandoned |